剂量验证系统软件KylinRay-Dose4D研发进展

      Progress in Development of Dose Verification System Software KylinRay-Dose4D

      • 摘要: 先进放射治疗技术使得治疗剂量能够更精准地适形患者肿瘤靶区,为患者提供精准治疗,但也出现了受照剂量在肿瘤边缘梯度越来越大的现象,对放射治疗剂量验证提出了更高的要求。该研究提出的剂量验证系统软件KylinRay-Dose4D能够进行患者治疗前计划验证、患者治疗时在体/实时剂量验证等,为物理师进行放射治疗计划修改提供重要参考,保证患者得到精确的治疗。该研究对KylinRay-Dose4D的总体设计和关键技术进行介绍,并通过临床病例对治疗前计划剂量验算、二维/三维剂量验证进行测试,测试结果显示KylinRay-Dose4D重建剂量与TPS计划剂量、实测剂量的二维/三维伽马通过率(3 mm/3%)均大于95%,表明KylinRay-Dose4D重建剂量满足临床应用需求。

         

        Abstract: Advanced radiotherapy technology enables the dose to more accurately conform to the tumor target area of the patient, providing accurate treatment for the patient, but the gradient of the patient’s radiation dose at the tumor edge is getting larger, which putting forward higher requirements for radiotherapy dose verification. The dose verification system software KylinRay-Dose4D can verify the patient’s pre-treatment plan and the in vivo/on-line dose during the patient’s treatment, providing important reference for the physicist to modify the radiotherapy plan and ensuring that the patient receives accurate treatment. This study introduces the overall design and key technologies of KylinRay-Dose4D, and tests the pre-treatment plan dose checking calculation and 2D/3D dose verification through clinical cases. The test results showed that the 2D/3D gamma pass rate (3 mm/3%) of KylinRay-Dose4D reconstructed dose compared with TPS plan dose and measured dose is larger than 95%, which indicating that the reconstructed dose of KylinRay-Dose4D meets the requirement of clinical application.

         

      /

      返回文章
      返回